Loading...
XSHE
002001
Market cap10bUSD
Dec 05, Last price  
24.75CNY
1D
2.15%
1Q
2.87%
Jan 2017
114.66%
IPO
114.84%
Name

Zhejiang Nhu Co Ltd

Chart & Performance

D1W1MN
XSHE:002001 chart
P/E
12.90
P/S
3.50
EPS
1.92
Div Yield, %
1.82%
Shrs. gr., 5y
-0.14%
Rev. gr., 5y
23.18%
Revenues
21.61b
+42.95%
1,256,656,7821,589,086,6421,747,875,3753,313,962,3392,898,225,2273,445,263,6203,803,991,6673,631,417,4844,237,635,1484,164,209,2113,822,542,9714,696,277,3276,235,108,1508,683,381,7467,620,982,93510,314,084,35414,797,989,09115,933,984,40315,116,537,00221,609,592,228
Net income
5.87b
+117.01%
61,181,42928,948,89177,071,1531,374,511,3661,018,339,1041,100,086,9091,164,392,570850,172,805882,120,714808,040,363402,067,7781,202,633,4561,704,413,4493,078,884,5522,168,616,2053,563,759,9394,356,010,6283,620,280,6262,704,238,7675,868,545,988
CFO
7.07b
+38.16%
082,903,582186,001,3061,193,294,1851,008,254,8911,304,750,9901,270,077,439985,864,8761,335,018,6381,079,736,503972,022,3841,190,295,7121,271,723,7593,660,322,3122,102,315,1943,122,807,3635,837,878,0514,361,481,0835,119,370,8637,073,064,183
Dividend
May 29, 20240.45 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zhejiang NHU Company Ltd. engages in the production and sale of nutritional products, flavor and fragrances, new polymer materials, and APIs in China. The company offers nutrition products, such as vitamin E, vitamin A, vitamin C, DL-Methionine, vitamin D3, biotin, coenzyme Q10, carotenoids, etc. for used in feed additives, and nutrition supplements of food, beverages, health food, etc.; and flavor and fragrance products comprising linalool series, citral series, cis-3-hexenol series, methyl dihydrojasmonate, raspberry ketone, and ligustral for used in personal care, cosmetic, and food fields. It also provides polymer materials, including polyphenylene sulfide and poly phthalamide for used in electronic and electrical, automotive, environmental protection, etc.; and APIs, such as moxifloxacin hydrochloride, vitamin A, vitamin D3, etc. to use as active pharmaceutical ingredients for processing and producing pharmaceutical preparations. The company was incorporated in 1999 and is based in Xinchang, China.
IPO date
Jun 25, 2004
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT